Literature DB >> 371645

Effects of tocainide on left ventricular performance at rest and during acute alterations in heart rate and systemic arterial pressure. An echocardiographic study.

W F Ryan, J S Karliner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 371645      PMCID： PMC486846          DOI： 10.1136/hrt.41.2.175

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  16 in total

1.  THE ANTIARRHYTHMIC PROPERTIES OF LIDOCAINE AND PROCAINE AMIDE. CLINICAL AND PHYSIOLOGIC STUDIES OF THEIR CARDIOVASCULAR EFFECTS IN MAN.

Authors:  D C HARRISON; J H SPROUSE; A G MORROW
Journal:  Circulation       Date:  1963-10       Impact factor: 29.690

2.  Favorable effects of oral maintenance digoxin therapy on left ventricular performance in normal subjects: echocardiographic study.

Authors:  M H Crawford; J S Karliner; R A O'Rourke; K W Amon
Journal:  Am J Cardiol       Date:  1976-12       Impact factor: 2.778

3.  Suppression of ventricular ectopic depolarizations by tocainide.

Authors:  R L Woosley; D G McDevitt; A S Nies; R F Smith; G R Wilkinson; J A Oates
Journal:  Circulation       Date:  1977-12       Impact factor: 29.690

4.  Effects of chronic digoxin administration on left ventricular performance in the normal conscious dog.

Authors:  F Mahler; J S Karliner; R A O'Rourke
Journal:  Circulation       Date:  1974-10       Impact factor: 29.690

5.  Antiarrhythmic and circulatory effects of Astra W36095, a new lidocaine-like agent.

Authors:  D J Coltart; T B Berndt; R Kernoff; D C Harrison
Journal:  Am J Cardiol       Date:  1974-07       Impact factor: 2.778

6.  Effects of oral equiblocking doses of a cardioselective and noncardioselective beta-adrenergic blocking agent on left ventricular function in the normal conscious dog.

Authors:  M M LeWinter; J S Karliner; R A O'Rourke
Journal:  Cardiovasc Res       Date:  1978-02       Impact factor: 10.787

7.  Antiarrhythmic effects of a lidocaine congener, tocainide, 2-amino-2',6'-propionoxylidide, in man.

Authors:  D G McDevitt; A S Nies; G R Wilkinson; R F Smith; R L Woosley; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1976-04       Impact factor: 6.875

8.  Echocardiographic determination of left ventricular stress-velocity relations.

Authors:  M A Quinones; W H Gaasch; J S Cole; J K Alexander
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690

9.  Clinical efficacy and pharmacokinetics of a new orally effective antiarrhythmic, tocainide.

Authors:  R A Winkle; P J Meffin; J W Fitzgerald; D C Harrison
Journal:  Circulation       Date:  1976-12       Impact factor: 29.690

10.  Long-term tocainide therapy for ventricular arrhythmias.

Authors:  R A Winkle; P J Meffin; D C Harrison
Journal:  Circulation       Date:  1978-05       Impact factor: 29.690
View more
  4 in total

Review 1.  Comparative hemodynamics of antiarrhythmic drugs.

Authors:  M Sami
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

Review 2.  Tocainide. A review of its pharmacological properties and therapeutic efficacy.

Authors:  B Holmes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-08       Impact factor: 9.546

3.  Successuful treatment of paramyotonia congenita (Eulenburg): muscle stiffness and weakness prevented by tocainide.

Authors:  K Ricker; A Haass; R Rüdel; R Böhlen; H G Mertens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-03       Impact factor: 10.154

Review 4.  New antiarrhythmic drugs.

Authors:  P F Nestico; J Morganroth; L N Horowitz
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.